Original Article

Chronic Opioid Users Are More Difficult to Sedate than Alcoholics and Controls

Authors: Rupal Patel, MD, Steven Clayton, MD, Eduardo Quintero, MD, Jeffrey Gill, MD

Abstract

Objectives: Diagnostic and therapeutic colonoscopy is performed using conscious sedation. Excessive alcohol users, chronic benzodiazepine and opioid users, and polysubstance users are commonly cited as difficult to sedate. Few studies have compared and analyzed medication dosages to achieve sedation in these groups.

Methods: The endoscopic database was searched for patients who underwent colonoscopy. A retrospective chart review was performed to determine whether each patient was an abuser/chronic user of opioids, benzodiazepines, marijuana, alcohol, or a combination of the above. The mean dose of fentanyl and versed administered in each group was compared.

Results: A total of 239 patients were enrolled. Compared with the alcohol and control groups, the opioid group used a statistically higher mean medication dosage to achieve sedation. The mean dose of fentanyl in the opioid group was 124 μg, the mean dose in the alcohol group was 101 μg, and the mean dose in the control group was 101 μg. The mean dose of midazolam in the opioid group was 4.1 mg, the mean dose in the alcohol group was 3.3 mg, and the mean dose in the control group was 3.3 mg.

Conclusions: Identifying patients who are difficult to sedate before colonoscopy is important because adequate sedation is associated with better adenoma detection, a better procedural completion rate, and patient satisfaction. In patients using daily opioids, it is important to anticipate the need for higher doses of medication to achieve adequate sedation.

 

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Rex DK. Colonoscopy. Gastrointest Endosc Clin N Am 2000;10:135-160.
 
2. Guidelines for colorectal cancer screening and surveillance. Gastrointest Endosc 2000;51:777-782.
 
3. Radaelli F, Meucci G, Sgroi G, et al. Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators. Am J Gastroenterol 2008;103:1122-1130.
 
4. Cook PJ, Flanagan R, James IM. Diazepam tolerance: effect of age, regular sedation, and alcohol. Br Med J (Clin Res Ed) 1984;289:351-353.
 
5. Substance Abuse and Mental Health Services Administration. Substance use and mental health estimates from the 2013 National Survey on Drug Use and Health: overview of findings. http://store.samhsa.gov/shin/content/NSDUH14-0904/NSDUH14-0904.pdf. Published September 4, 2014. Accessed September 18, 2015.
 
6. Parsells Kelly J, Cook SF, Kaufman DW, et al. Prevalence and characteristics of opioid use in the US adult population. Pain 2008;138:507-513.
 
7. Saper JR, Lake AE 3rd, Bain PA, et al. A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoring. Headache 2010;50:1175-1193.
 
8. Zandstra SM, Furer JW, van de Lisdonk EH, et al. Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 2002;37:139-144.
 
9. de Wit M, Wan SY, Gill S, et al. Prevalence and impact of alcohol and other drug use disorders on sedation and mechanical ventilation: a retrospective study. BMC Anesthesiol 2007;7:3.
 
10. National Institutes of Health. Alcohol use and alcohol use disorders in the United States: main findings from the 2001-2002 national epidemiologic survey on alcohol and related conditions (NESARC). http://pubs.niaaa.nih.gov/publications/NESARC_DRM/NESARCDRM.pdf. Published January 2006. Accessed September 18, 2015.
 
11. Vijan S, Inadomi J, Hayward RA, et al. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther 2004;20:507-515.
 
12. Eberl S, Preckel B, Fockens P, et al. Analgesia without sedatives during colonoscopies: worth considering? Tech Coloproctol 2012;16:271-276.
 
13. Inadomi JM, Gunnarsson CL, Rizzo JA, et al. Projectedincreased growth rate of anesthesia professional-delivered sedation for colonoscopy and EGD in the United States: 2009 to 2015. Gastrointest Endosc 2010;72:580-586.
 
14. Eberl S, Polderman JA, Preckel B, et al. Is ‘‘really conscious’’ sedation with solely an opioid an alternative to everyday used sedation regimes for colonoscopies in a teaching hospital? Midazolam/fentanyl, propofol/alfentanil, or alfentanil only for colonoscopy: a randomized trial. Tech Coloproctol 2014;18:745-752.
 
15. Jamison RN, Mao J. Opioid analgesics. Mayo Clin Proc 2015;90:957-968.
 
16. Osborn TM, Sandler NA. The effects of preoperative anxiety on intravenous sedation. Anesth Prog 2004;51:46-51.
 
17. Department of Veterans Affairs. National Center for Veterans Analysis and Statistics. Quick Facts. http://www.va.gov/vetdata/Quick_Facts.asp. Published January 7, 2015. Accessed September 18, 2015.
 
18. Green BB, Coronado GD, Devoe JE, et al. Navigating the murky waters of colorectal cancer screening and health reform. Am J Public Health 2014;104:982-986.